(Q82847250)
Statements
A phase I safety and pharmacokinetic study of the death receptor 5 agonistic antibody PRO95780 in patients with advanced malignancies (English)
Roy S Herbst
Razelle Kurzrock
D Ross Camidge
Michael S Gordon
S Gail Eckhardt
Blythe Durbin
Josephine Ing
Tanyifor M Tohnya
Jason Sager
Avi Ashkenazi
Gordon Bray
David Mendelson